A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS

被引：44
作者：
CARETTE, S
CALIN, A
MCCAFFERTY, JP
WALLIN, BA
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1989年 / 32卷 / 02期
关键词：
D O I：
10.1002/anr.1780320208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 165
页数：8
相关论文
共 50 条
  • [21] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
  • [22] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, I. B.
    Kavanaugh, A.
    Gottlieb, A. B.
    Puig, L.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Doyle, M. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 107 - 107
  • [23] Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
    Schett, Georg
    Wollenhaupt, Jurgen
    Papp, Kim
    Joos, Rik
    Rodrigues, Jude F.
    Vessey, Adele R.
    Hu, ChiaChi
    Stevens, Randall
    de Vlam, Kurt L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3156 - 3167
  • [24] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-blind, Placebo-Controlled PSUMMIT I Study
    Rahman, Proton
    Kavanaugh, Arthur
    Gottlieb, Alice
    Puig, Lluis
    Ritchlin, Christopher
    McInnes, Iain
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 983 - 983
  • [25] Double-blind, placebo-controlled study of quetiapine
    Chawla, J. M.
    BIPOLAR DISORDERS, 2008, 10 : 42 - 42
  • [26] Treatment of patients with undifferentiated arthritis with methotresate: a double-blind, placebo-controlled, randomized
    van Dongen, H
    van Aken, J
    Lard, LR
    Ronday, HK
    Speyer, I
    Westedt, ML
    Allaart, CF
    Breedveld, FC
    Huizinga, TW
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4058 - 4059
  • [27] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [28] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Choy, EHS
    Sharp, JT
    Ory, PA
    Perdok, RJ
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
  • [29] Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: Rationale and design of a randomized, double-blind, placebo-controlled study
    Gladman, D
    Keystone, E
    Gottlieb, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P60 - P60
  • [30] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137
12345